Sirén AL et al. |
Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats. |
1993 |
Stroke |
pmid:8506560
|
Lindsberg PJ et al. |
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. |
1990 |
Stroke |
pmid:2219210
|
Sirén AL et al. |
Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. |
1992 |
Stroke |
pmid:1440713
|
Joseph R et al. |
Effect of therapy on platelet activating factor-induced aggregation in acute stroke. |
1989 |
Stroke |
pmid:2718200
|
Joseph R and Welch KM |
Granulocytes, platelet activating factor, and stroke. |
1989 |
Stroke |
pmid:2756548
|
Uhl E et al. |
Influence of platelet-activating factor on cerebral microcirculation in rats: part 1. Systemic application. |
1999 |
Stroke |
pmid:10187894
|
Uhl E et al. |
Influence of platelet-activating factor on cerebral microcirculation in rats: part 2. Local application. |
1999 |
Stroke |
pmid:10187895
|
Bielenberg GW et al. |
Infarct reduction by the platelet activating factor antagonist apafant in rats. |
1992 |
Stroke |
pmid:1731428
|
Joseph R et al. |
Effect of ticlopidine and aspirin on platelet ionized calcium in ischemic stroke. |
1991 |
Stroke |
pmid:2024285
|
Kochanek PM et al. |
Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain. |
1990 |
Stroke |
pmid:2309270
|
Feuerstein G et al. |
Platelet-activating factor. A putative mediator in central nervous system injury? |
1990 |
Stroke |
pmid:2237991
|
Yoshida H et al. |
Platelet-activating factor acetylhydrolase in red cell membranes. Does decreased activity impair erythrocyte deformability in ischemic stroke patients? |
1993 |
Stroke |
pmid:8418541
|
Nishida K and Markey SP |
Platelet-activating factor in brain regions after transient ischemia in gerbils. |
1996 |
Stroke |
pmid:8610322
|
Wei Y et al. |
Structure of a microbial homologue of mammalian platelet-activating factor acetylhydrolases: Streptomyces exfoliatus lipase at 1.9 A resolution. |
1998 |
Structure |
pmid:9562561
|
Anderson BO et al. |
The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. |
1991 |
Surg Gynecol Obstet |
pmid:1851337
|
Biffl WL et al. |
Neutrophil apoptosis is delayed by trauma patients' plasma via a mechanism involving proinflammatory phospholipids and protein kinase C. |
2001 |
Surg Infect (Larchmt) |
pmid:12593704
|
Denham W and Norman J |
The potential role of therapeutic cytokine manipulation in acute pancreatitis. |
1999 |
Surg. Clin. North Am. |
pmid:10470326
|
Fukuoka T et al. |
The platelet activating factor as a pivotal mediator of shock after liver ischemia. |
1995 |
Surg. Today |
pmid:7633127
|
Ono S et al. |
Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC. |
1993 |
Surg. Today |
pmid:8467174
|
Abu-Zidan FM |
Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. |
1998 |
Surgery |
pmid:9481416
|
Yaffe MB et al. |
Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. |
1999 |
Surgery |
pmid:10455891
|
Botha AJ et al. |
Postinjury neutrophil priming and activation: an early vulnerable window. |
1995 |
Surgery |
pmid:7638753
|
Werner J et al. |
Multidrug strategies are effective in the treatment of severe experimental pancreatitis. |
2012 |
Surgery |
pmid:21982067
|
Biffl WL et al. |
Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation. |
2003 |
Surgery |
pmid:12874587
|
Unno N et al. |
Single nucleotide polymorphism (G994-->T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass. |
2002 |
Surgery |
pmid:12110797
|
Partrick DA et al. |
Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway. |
1997 |
Surgery |
pmid:9288123
|
Kim FJ et al. |
Disparate signal transduction in neutrophil CD18 adhesion receptor expression versus superoxide generation. |
1994 |
Surgery |
pmid:8047994
|
Schurr MJ et al. |
Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. |
1997 |
Surgery |
pmid:9142146
|
Takada Y et al. |
Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. |
1998 |
Surgery |
pmid:9626320
|
Porras-Reyes BH and Mustoe TA |
Platelet-activating factor: improvement in wound healing by a chemotactic factor. |
1992 |
Surgery |
pmid:1557687
|
Cuschieri J et al. |
Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. |
2002 |
Surgery |
pmid:12219006
|
Read RA et al. |
Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11b adhesion. |
1993 |
Surgery |
pmid:8342134
|
Liu T et al. |
Improved preservation of the rat liver for orthotopic liver transplantation: use of University of Wisconsin-lactobionate solution and retrograde reflushing. |
1990 |
Surgery |
pmid:2237771
|
Wang KS et al. |
Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats. |
1993 |
Surgery |
pmid:8417492
|
Bazan NG and Allan G |
Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids. |
1997 |
Surv Ophthalmol |
pmid:9154273
|
Eser A et al. |
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients. |
2016 |
Taiwan J Obstet Gynecol |
pmid:26927250
|
Miwa M |
[Catabolism of PAF and its regulation]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024018
|
Oda M et al. |
[PAF and diseases]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024019
|
Fukuda T and Makino S |
[Allergy and PAF]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024020
|
Yanoshita R |
[Phospholipid alteration and activation of phospholipase A2 in ischemic heart]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024024
|
Karasawa K and Nojima S |
[Production and application of antibodies to PAF]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024029
|
Tsujimoto M and Hori T |
[Activation of phospholipase A2 by cytokines]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:2024038
|
Ishii S and Shimizu T |
[Platelet-activating factor (PAF) receptor-related pathophysiology]. |
1999 |
Tanpakushitsu Kakusan Koso |
pmid:10396985
|
Okiji T and Murota S |
[Chemical mediators]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:1901997
|
Mizoguchi H |
[Erythropoietin and thrombopoietin]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:1651533
|
Shindou H and Shimizu T |
[New development of lysophospholipid acyltransferases]. |
2009 |
Tanpakushitsu Kakusan Koso |
pmid:19205351
|
Karasawa K |
[Physiological role of novel metabolic pathway of platelet-activating factor(PAF): PAF-dependent transacetylation]. |
2001 |
Tanpakushitsu Kakusan Koso |
pmid:11193332
|
Masugi F et al. |
[Platelet-activating factor and antihypertensive polar renomedullary lipid: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine]. |
1982 |
Tanpakushitsu Kakusan Koso |
pmid:6758041
|
Terasawa M |
[Platelet-activating factor (PAF) antagonists]. |
1991 |
Tanpakushitsu Kakusan Koso |
pmid:1850862
|
TatarskiÄ AR et al. |
[Use of plateletpheresis in the treatment of bronchial asthma]. |
1991 |
Ter. Arkh. |
pmid:2063345
|